Percuros has been awarded three more grants and will launch three projects:
- PREPARED – A EUROSTARS funded project together with two organisations from Denmark, Atonomics and The Parker Institute (Copenhagen University Hospital), both based in Copenhagen. The program will allow the development of new point-of-care assays for therapeutic monitoring of rheumatoid arthritis.
- CANCER – A European H2020 MSCA RISE grant to study how the new cancer immunotherapy checkpoint blockers affect patients in terms of their quality of life and the impact of such treatment on their long term immune status.
- ARCATOR - A three-year project funded by EUROSTARS together with SIMFO GmbH, based in Bayreuth (Germany) to work on mid-throughput assays for measuring circulating tumour cells in liquid biopsies.
Percuros BV is a biotech company
operating in the area of drug discovery research and optical imaging of pathways. It is working in a number of diverse areas including skeletal biology, stem cell tracking, cardiovascular biology and oncology.
Read more about us